Literature DB >> 26483992

Human Anaplasmosis in Acute Febrile Patients during Scrub Typhus Season in Korea.

Myung-Jo You1, Won-Il Kim1, Ho-Seong Cho1, Gee-Wook Shin1, Jeong-Hwan Hwang2, Chang-Seop Lee2.   

Abstract

Entities:  

Year:  2015        PMID: 26483992      PMCID: PMC4607771          DOI: 10.3947/ic.2015.47.3.181

Source DB:  PubMed          Journal:  Infect Chemother        ISSN: 1598-8112


× No keyword cloud information.
Dear Editor, Scrub typhus is an infectious disease caused by Orientia tsutsugamushi, and has become one of the most prevalent human diseases in Korea; since 2004, the disease has spread widely in the southwestern provinces of the country and is becoming endemic [1]. Anaplasmosis is caused by the bacterium Anaplasma phagocytophilum, and leads to human granulocytic ehrlichiosis (HGE) (human granulocytic anaplasmosis). A. phagocytophilum has been detected in Haemaphysalis longicornis, Ixodes nipponensis and I. persulcatus ticks in Korea [2]. The clinical presentations of scrub typhus/anaplasmosis are similar; symptoms that typically develop within 1-2 weeks of infection include fever, headache and malaise. Evidence has been suggesting the presence of A. phagocytophilum infections in South Korea [3]. Although scrub typhus is very common, to date, there has been only one confirmed report of anaplasmosis in Korea [4]. Serum specimens from 100 patients (≥ 18 years old) with acute febrile disease were studied using indirect immunofluorescence assay against O. tsutsugamushi for scrub typhus and real-time PCR for human anaplasmosis. The serum enrolled in this study was collected during the scrub typhus season in Korea from September 2011 to December 2012. The mean age of patients with febrile disease was 57.3 years. Forty-one acute febrile illness patients were positive for O. tsutsugamushi (41%), but none tested positive for A. phagocytophilum. HGA was first identified in the United States in 1994 [5] and subsequently in countries in Europe and Asia. A high percentage of Korean water deer (63.6%) were found to host A. phagocytophilum [6]. In a previous study, 1.8% of serum samples from patients with acute fever were positive for A. phagocytophilum on immunofluorescence antibody test [7]. The number of anaplasmosis cases reported to the CDC has increased steadily since the disease became reportable, from 348 cases in 2000, to 1,761 cases in 2010. The incidence of anaplasmosis has also increased, from 1.4 cases per million persons in 2000 to 6.1 cases per million persons in 2010 [8]. Since the presence of human anaplasmosis has been confirmed in Korea, this information provides a basis for treating and monitoring febrile patients with a history of contact with ticks. As both scrub typhus and anaplasmosis are potentially serious illnesses, urgent medical attention is required on suspicion of infection. In this study, we found acute febrile illness patients in Korea to have scrub typhus, with no evidence of anaplasmosis. Detailed studies are needed to isolate and identify Anaplasma spp. from humans, animals and vector ticks/mites in Korea from different regions to confirm their presence and capacity to cause disease.
  8 in total

1.  New genetic variants of Anaplasma phagocytophilum and Anaplasma bovis from Korean water deer (Hydropotes inermis argyropus).

Authors:  Jun-gu Kang; Sungjin Ko; Young-Jun Kim; Hyo-Jin Yang; Hang Lee; Nam-Shik Shin; Kyoung-seong Choi; Joon-Seok Chae
Journal:  Vector Borne Zoonotic Dis       Date:  2011-03-21       Impact factor: 2.133

2.  Epidemiology of human ehrlichiosis and anaplasmosis in the United States, 2001-2002.

Authors:  Linda J Demma; Robert C Holman; Jennifer H McQuiston; John W Krebs; David L Swerdlow
Journal:  Am J Trop Med Hyg       Date:  2005-08       Impact factor: 2.345

3.  Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.

Authors:  S M Chen; J S Dumler; J S Bakken; D H Walker
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

4.  Serologic and molecular detection of Ehrlichia chaffeensis and Anaplasma phagocytophila (human granulocytic ehrlichiosis agent) in Korean patients.

Authors:  Eun-jeong Heo; Jin-ho Park; Ja-ryong Koo; Man-suk Park; Mi-yeoun Park; J Stephen Dumler; Joon-seok Chae
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

5.  Detection of antibodies to Anaplasma phagocytophilum and Ehrlichia chaffeensis antigens in sera of Korean patients by western immunoblotting and indirect immunofluorescence assays.

Authors:  Jin-Ho Park; Eun-Jeong Heo; Kyoung-Seong Choi; J Stephen Dumler; Joon-Seok Chae
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

6.  Current situation of scrub typhus in South Korea from 2001-2013.

Authors:  Hyeong-Woo Lee; Pyo Yun Cho; Sung-Ung Moon; Byoung-Kuk Na; Yoon-Joong Kang; Youngjoo Sohn; Seung-Ki Youn; Yeongseon Hong; Tong-Soo Kim
Journal:  Parasit Vectors       Date:  2015-04-19       Impact factor: 3.876

7.  Human granulocytic anaplasmosis, South Korea, 2013.

Authors:  Kye-Hyung Kim; Jongyoun Yi; Won Sup Oh; Nak-Hyun Kim; Su Jin Choi; Pyoeng Gyun Choe; Nam-Joong Kim; Jong-Koo Lee; Myoung-don Oh
Journal:  Emerg Infect Dis       Date:  2014-10       Impact factor: 6.883

8.  Microbial pathogens in ticks, rodents and a shrew in northern Gyeonggi-do near the DMZ, Korea.

Authors:  Joon Seok Chae; Do Hyeon Yu; Smriti Shringi; Terry A Klein; Heung Chul Kim; Sung Tae Chong; In Yong Lee; Janet Foley
Journal:  J Vet Sci       Date:  2008-09       Impact factor: 1.672

  8 in total
  2 in total

1.  Human granulocytic anaplasmosis in Kinmen, an offshore island of Taiwan.

Authors:  Kun-Hsien Tsai; Lo-Hsuan Chung; Chia-Hao Chien; Yu-Jung Tung; Hsin-Yi Wei; Tsai-Ying Yen; Pei-Yun Shu; Hsi-Chieh Wang
Journal:  PLoS Negl Trop Dis       Date:  2019-09-20

2.  Prevalence of Orientia tsutsugamushi, Anaplasma phagocytophilum and Leptospira interrogans in striped field mice in Gwangju, Republic of Korea.

Authors:  Mi-Seon Bang; Choon-Mee Kim; Jung Wook Park; Jae Keun Chung; Dong-Min Kim; Na Ra Yun
Journal:  PLoS One       Date:  2019-08-16       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.